579 related articles for article (PubMed ID: 27277580)
41. High hydrostatic pressure enables almost 100% refolding of recombinant human ciliary neurotrophic factor from inclusion bodies at high concentration.
Wang Q; Liu Y; Zhang C; Guo F; Feng C; Li X; Shi H; Su Z
Protein Expr Purif; 2017 May; 133():152-159. PubMed ID: 28323167
[TBL] [Abstract][Full Text] [Related]
42. Improved Refolding of a Human IgG1 Fc (CH2-CH3) Scaffold from Its Inclusion Body in E. coli by Alkaline Solubilization.
Ishikawa S; Ishikawa H; Sato A
Biol Pharm Bull; 2022; 45(3):284-291. PubMed ID: 35228394
[TBL] [Abstract][Full Text] [Related]
43. Refolding and purification of recombinant L-asparaginase from inclusion bodies of E. coli into active tetrameric protein.
Upadhyay AK; Singh A; Mukherjee KJ; Panda AK
Front Microbiol; 2014; 5():486. PubMed ID: 25309524
[TBL] [Abstract][Full Text] [Related]
44. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization.
Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T
Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370
[TBL] [Abstract][Full Text] [Related]
45. Solubilization and refolding with simultaneous purification of recombinant human stem cell factor.
Wang C; Liu J; Wang L; Geng X
Appl Biochem Biotechnol; 2008 Feb; 144(2):181-9. PubMed ID: 18456949
[TBL] [Abstract][Full Text] [Related]
46. MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies.
Kuo MM; Nguyen PH; Jeon YH; Kim S; Yoon SM; Choe S
Microb Cell Fact; 2014 Feb; 13(1):29. PubMed ID: 24559319
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the purification of biologically active IL-7 cytokine expressed in Escherichia coli and Pichia pastoris.
Zaremba-Czogalla M; Stumpp C; Bonifacio E; Paul R
Protein Expr Purif; 2015 Jun; 110():65-71. PubMed ID: 25703052
[TBL] [Abstract][Full Text] [Related]
48. Using High Pressure and Alkaline pH for Refolding.
Morganti L; Chura-Chambi RM
Methods Mol Biol; 2023; 2617():177-187. PubMed ID: 36656524
[TBL] [Abstract][Full Text] [Related]
49. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
[TBL] [Abstract][Full Text] [Related]
50. Expression, purification, refolding and in vitro recovery of active full length recombinant human gelatinase MMP-9 in Escherichia coli.
Mohseni S; Moghadam TT; Dabirmanesh B; Khajeh K
Protein Expr Purif; 2016 Oct; 126():42-48. PubMed ID: 27164034
[TBL] [Abstract][Full Text] [Related]
51. An efficient in vitro refolding of recombinant bacterial laccase in Escherichia coli.
Mollania N; Khajeh K; Ranjbar B; Rashno F; Akbari N; Fathi-Roudsari M
Enzyme Microb Technol; 2013 May; 52(6-7):325-30. PubMed ID: 23608500
[TBL] [Abstract][Full Text] [Related]
52. A single step method for the solubilization and refolding of recombinant protein from E. coli inclusion bodies.
Crivelli E; Cardamone M; Puri NK
Aust J Biotechnol; 1991 Apr; 5(2):78-80, 86. PubMed ID: 1367324
[TBL] [Abstract][Full Text] [Related]
53. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
[TBL] [Abstract][Full Text] [Related]
54. Recovery of active N-acetyl-D-glucosamine 2-epimerase from inclusion bodies by solubilization with non-denaturing buffers.
Lu SC; Lin SC
Enzyme Microb Technol; 2012 Jan; 50(1):65-70. PubMed ID: 22133442
[TBL] [Abstract][Full Text] [Related]
55. Microfluidic chips with multi-junctions: an advanced tool in recovering proteins from inclusion bodies.
Yamaguchi H; Miyazaki M
Bioengineered; 2015; 6(1):1-4. PubMed ID: 25531187
[TBL] [Abstract][Full Text] [Related]
56. On-column refolding purification of DT389-hIL13 recombinant protein expressed in Escherichia coli.
Sun W; Dai X; Zheng Y; Wang J; Hou L; Du J; Hu HG
Protein Expr Purif; 2011 Jan; 75(1):83-8. PubMed ID: 20851185
[TBL] [Abstract][Full Text] [Related]
57. Refolding of alpha 1-antitrypsin expressed as inclusion bodies in Escherichia coli: characterization of aggregation.
Kwon KS; Lee S; Yu MH
Biochim Biophys Acta; 1995 Mar; 1247(2):179-84. PubMed ID: 7696306
[TBL] [Abstract][Full Text] [Related]
58. Purification of a crystallin domain of Yersinia crystallin from inclusion bodies and its comparison to native protein from the soluble fraction.
Jobby MK; Sharma Y
Biomed Chromatogr; 2006 Sep; 20(9):956-63. PubMed ID: 16470515
[TBL] [Abstract][Full Text] [Related]
59. Refolding and simultaneous purification of recombinant human proinsulin from inclusion bodies on protein-folding liquid-chromatography columns.
Yuan J; Zhou H; Yang Y; Li W; Wan Y; Wang L
Biomed Chromatogr; 2015 May; 29(5):777-82. PubMed ID: 25378200
[TBL] [Abstract][Full Text] [Related]
60. Purification and renaturation of recombinant human lymphotoxin (tumour necrosis factor beta) expressed in Escherichia coli as inclusion bodies.
Jin H; Uddin MS; Huang YL; Teo WK
J Chem Technol Biotechnol; 1994 Jan; 59(1):67-72. PubMed ID: 7764497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
